| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.006 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.32 | 0.01 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |